Viewing Study NCT03937869


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-02-08 @ 9:15 PM
Study NCT ID: NCT03937869
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2019-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety of a Single Oral Dose of Solosecâ„¢ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Sponsor: Lupin Research Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module